Register now for the 9th annual Ruesch Center Symposium on November 30 and December 1 at the Washington Hilton
2018 Luminary Awards in GI Cancers
Join us in honoring those who have made transformative strides in the lives of patients with gastrointestinal cancers
The 2018 Ruesch Center Annual Report
Highlights of the Ruesch Center from the past year include our latest in research and clinical trials, partnerships regionally and internationally, and our education, advocacy and outreach efforts.
Relentlessly fighting a smarter war against GI cancer by partnering with patients based on their unique needs, the Ruesch Center is committed to providing you with the highest standard of care and individualized cures.
Search our current GI clinical trials offered through the MedStar Georgetown Cancer Institute
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
-
TGen leader earns award for advances in treating pancreatic cancer
-
Atezolizumab Plus Bevacizumab Shows Durable Activity in Advanced HCC
-
Update on HCC treatment by Dr. Aiwu Ruth He
-
OncLive® and The Ruesch Center Announce the Honorees of The Luminary Awards in GI Cancers
-
At Cancer Bell-Ringing Ceremonies, Some Are Angry Onlookers
-
Deep, Durable Responses Seen With Atezolizumab Combo For Frontline HCC Treatment
-
Treating a Rare Gastrointestinal Cancer: Meeghan DeCagna’s Story
-
Treating GI Cancers with Proton Therapy: Ask Dr. Keith Unger
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver our quarterly newsletter, monthly updates and other announcements to your Inbox with information on upcoming special events, current clinical trials and cutting edge research and trends in the GI cancer field.